Pivato, Carlo Andrea
 Distribuzione geografica
Continente #
NA - Nord America 1.710
AS - Asia 1.035
EU - Europa 368
SA - Sud America 196
Continente sconosciuto - Info sul continente non disponibili 62
AF - Africa 29
OC - Oceania 2
Totale 3.402
Nazione #
US - Stati Uniti d'America 1.655
SG - Singapore 578
CN - Cina 210
BR - Brasile 169
IT - Italia 95
VN - Vietnam 82
FI - Finlandia 65
IE - Irlanda 53
DE - Germania 44
HK - Hong Kong 34
GB - Regno Unito 31
CA - Canada 29
IN - India 28
BD - Bangladesh 16
IQ - Iraq 15
SE - Svezia 15
FR - Francia 14
AR - Argentina 10
ID - Indonesia 10
MX - Messico 10
NG - Nigeria 9
PL - Polonia 9
TR - Turchia 9
NL - Olanda 8
RU - Federazione Russa 8
UA - Ucraina 8
ES - Italia 6
JP - Giappone 6
MY - Malesia 5
PK - Pakistan 5
PY - Paraguay 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
JM - Giamaica 4
PH - Filippine 4
TH - Thailandia 4
TN - Tunisia 4
BB - Barbados 3
CL - Cile 3
EC - Ecuador 3
JO - Giordania 3
KE - Kenya 3
MA - Marocco 3
UZ - Uzbekistan 3
AL - Albania 2
AU - Australia 2
BO - Bolivia 2
EG - Egitto 2
GT - Guatemala 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
PE - Perù 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
KR - Corea 1
KW - Kuwait 1
LT - Lituania 1
ML - Mali 1
NP - Nepal 1
OM - Oman 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 3.340
Città #
Singapore 237
San Jose 235
Ashburn 166
The Dalles 97
Shanghai 82
Council Bluffs 79
Dallas 70
Helsinki 65
Beijing 54
Dublin 52
Los Angeles 48
New York 46
Boardman 42
Santa Clara 41
Milan 34
Hong Kong 33
Ho Chi Minh City 27
Chandler 24
Buffalo 20
Hanoi 20
São Paulo 20
Phoenix 18
Wilmington 17
Pune 16
Falkenstein 13
Princeton 13
Brooklyn 12
Chicago 12
San Mateo 11
Rome 10
Benin City 9
Houston 8
Queens 8
Warsaw 8
Charlotte 6
Dhaka 6
Lawrence 6
Mexico City 6
Montreal 6
Reston 6
San Diego 6
Amsterdam 5
Düsseldorf 5
Fairfield 5
Manchester 5
Naples 5
Rio de Janeiro 5
Seattle 5
Tokyo 5
Baghdad 4
Boston 4
Brasília 4
Campinas 4
Da Nang 4
Denver 4
Haiphong 4
Las Vegas 4
London 4
Munich 4
Norwalk 4
Omaha 4
Orem 4
Philadelphia 4
San José 4
Turin 4
Abbeville 3
Amman 3
Asunción 3
Biên Hòa 3
Bologna 3
Bridgetown 3
Curitiba 3
Dubai 3
Guarulhos 3
Hillsboro 3
Indianapolis 3
Johannesburg 3
Kuala Lumpur 3
Lahore 3
Manila 3
Miami 3
Minneapolis 3
Nairobi 3
Paris 3
Phuket 3
Porto Alegre 3
San Francisco 3
Stockholm 3
Tashkent 3
The Bronx 3
Toronto 3
Triggiano 3
Washington 3
Woodbridge 3
Yonkers 3
Acworth 2
Albuquerque 2
Ankara 2
Atlanta 2
Belo Horizonte 2
Totale 1.893
Nome #
A Complicated Case of Resistant Hypertension 87
Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel 82
Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial 82
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering 80
Cardiovascular safety of assisted reproductive technology: a meta-analysis 78
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry 78
Safety and efficacy of polymer-free drug-eluting stents: Amphilimus-eluting Cre8 versus biolimus-eluting biofreedom stents 72
Depression and ischemic heart disease 69
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 66
Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry) 64
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis 64
Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside 64
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention 62
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 62
Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index 62
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 62
PROGNOSTIC VALUE OF HIGH-SENSITIVITY C-REATIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION 62
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 61
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 61
The Cre8 amphilimus-eluting stent for the treatment of coronary artery disease: safety and efficacy profile 60
Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD 60
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry 59
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft 58
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 57
Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis 57
Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis 56
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent 55
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 55
Pericardial Effusion Provoking Atrial Fibrillation After Cardiac Surgery: JACC Review Topic of the Week 54
Types of myocardial injury and mid-term outcomes in patients with COVID-19 53
New Criteria to Identify Patients at Higher Risk for Cardiovascular Complications After Percutaneous Coronary Intervention 53
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 53
Long-term (≥15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY Registry) 52
One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients 52
Feasibility and safety of same-day discharge after elective transcatheter interventions: experience of a high-volume center [Fattibilità e sicurezza della dimissione in giornata per procedure elettive di cardiologia interventistica in un centro ad alto volume] 52
Bileaflet Tethering With Preserved LV Geometry and Function 51
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 51
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 51
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 50
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients needing short dual antiplatelet therapy. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 50
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 48
Single or dual antiplatelet therapy after transcatheter aortic valve implantation. A meta-analysis of randomized controlled trials 48
One-year clinical outcome and predictors of ischemic and hemorrhagic events after percutaneous coronary intervention in elderly and very elderly patients 47
Perioperative Management of P2Y12 Inhibitors in Patients Undergoing Cardiac Surgery within 1 Year of PCI 45
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention 45
Impact of RAAS Inhibitors on Clinical Outcome and Mortality in Patients With STEMI During the COVID-19 Era: A Multicenter Observational Study 44
MitraClip Treatment for Severe Mitral Regurgitation Due to Chordae Rupture Following Impella CP Support in a Patient With Severe Aortic Stenosis 43
One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in women at high-bleeding risk: Insights from the POEM trial 43
Left atrial appendage closure with the II generation Ultraseal device: An international registry. The LIGATE study 42
SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis 42
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction 41
One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in patients at high-bleeding risk: an individual patient data pooled analysis of the SENIOR and POEM trials 39
Early Right Heart Remodeling in Patients With Mitral Valve Prolapse 38
GLP-1 receptor agonists and coronary plaques regression in diabetic patients after acute coronary syndromes 38
One-Month Dual Antiplatelet Therapy in Patients With Chronic and Acute Coronary Syndromes Treated With Bioresorbable Polymer Everolimus-Eluting Stents 33
Clinical outcomes of percutaneous coronary interventions after transcatheter aortic valve replacement 31
Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation 28
Revascularization strategies in Non-ST segment elevation myocardial infarction: the clash continues 22
Early oral anticoagulation monotherapy after PCI: Insights from the POEM trial 22
Cardiovascular safety of assisted reproductive technologies: what is next? 20
Impact of Valve Frame Height on PCI Outcomes After TAVR 19
Reply 17
Ultrasound evaluation of placental volume and placental vascular indices in women developing hypertensive disorders in pregnancy compared to controls: a systematic review and meta-analysis 17
Antithrombotic therapy: less is more or the more the better? 16
Left atrial appendage occlusion in patients with atrial fibrillation: focus on current evidence and commercially available devices 15
Sex disparities continue to characterise the management of non‐ST‐elevation acute coronary syndrome 14
Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry 10
Percutaneous left atrial appendage closure versus non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk 10
One-month dual antiplatelet therapy after biodegradable-polymer everolimus-eluting stent implantation in diabetic patients at high bleeding risk 9
Prognostic Value of Pre-operative Atrial Fibrillation in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation 9
Gender Differences after Transcatheter Aortic Valve Replacement (TAVR): Insights from the Italian Clinical Service Project 9
Percutaneous Treatment of Paravalvular Leak in Rapid-Deployment Bioprosthetic Aortic Valve With Balloon Dilation 8
Long-term cardiovascular risk of pre-eclampsia 6
REPLY: Short vs Tall Frames in PCI Does Left Main-Indexed Positioning Matter? 6
Outcomes of percutaneous coronary interventions after transcatheter aortic valve replacement 5
Impact of Valve Frame Height on PCI Outcomes After TAVI 5
Cardiovascular Safety of Fertility Therapy: A Systematic Review and Meta-Analysis 4
One-month dual antiplatelet therapy following stent implantation in patients with acute coronary syndromes and high bleeding risk 4
PRASUGREL OR CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AT DIFFERENT THROMBOTIC RISK: RESULTS FROM THE PROMETHEUS STUDY 3
Totale 3.402
Categoria #
all - tutte 23.660
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.660


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202224 0 0 0 6 0 0 2 5 2 2 6 1
2022/2023225 12 0 6 19 19 16 14 9 42 48 36 4
2023/2024314 23 36 77 23 7 36 23 13 5 20 26 25
2024/2025510 5 2 5 5 13 63 29 34 87 135 74 58
2025/20261.526 211 94 77 134 66 63 418 68 69 110 69 147
2026/2027763 124 132 446 61 0 0 0 0 0 0 0 0
Totale 3.402